U.S. markets closed

Anavex Life Sciences Corp. (AVXL)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
13.02-0.04 (-0.31%)
At close: 4:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 2/25/2021
Current
12/31/20209/30/20206/30/20203/31/202012/31/2019
Market Cap (intraday) 5
858.87M361.60M282.31M295.60M184.79M147.84M
Enterprise Value 3
811.51M332.35M254.69M269.04M157.34M125.65M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/AN/A
Price/Book (mrq)
18.1113.2811.4411.927.127.29
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/AN/A
Enterprise Value/EBITDA 6
-24.81-35.37-33.92-33.19-20.44-16.48

Trading Information

Stock Price History

Beta (5Y Monthly) 0.50
52-Week Change 3216.02%
S&P500 52-Week Change 323.92%
52 Week High 328.70
52 Week Low 32.20
50-Day Moving Average 39.52
200-Day Moving Average 36.03

Share Statistics

Avg Vol (3 month) 33.9M
Avg Vol (10 day) 31.66M
Shares Outstanding 569.49M
Float 67.14M
% Held by Insiders 13.63%
% Held by Institutions 119.19%
Shares Short (Feb 11, 2021) 44.01M
Short Ratio (Feb 11, 2021) 40.49
Short % of Float (Feb 11, 2021) 45.97%
Short % of Shares Outstanding (Feb 11, 2021) 45.77%
Shares Short (prior month Jan 14, 2021) 45.58M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Oct 06, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 29, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-41.04%
Return on Equity (ttm)-76.23%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-27.54M
Diluted EPS (ttm)-0.46
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)47.36M
Total Cash Per Share (mrq)0.68
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)6.76
Book Value Per Share (mrq)0.69

Cash Flow Statement

Operating Cash Flow (ttm)-23.43M
Levered Free Cash Flow (ttm)-13.49M